Medical specialists from France tagged as investigators in clinical trials studying Fatty Liver

Total 64 results

ALBERT TRAN, Ph D
Seen in:
- Nice, Chu de Nice Hopital de L'Archet
- Nice, Hepatogastroenterology, Hôpital l'Archet, CHU de Nice
Trials:
- NCT00914446 (Principal Investigator)
- NCT00886301 (Sub-Investigator)
Conditions:
Anty Rodolphe
Seen in:
- Nice, CHU de Nice
Trials:
- NCT04835831 (Principal Investigator)
Conditions:
- Non-Alcoholic Fatty Liver Disease (NAFLD
Bénédicte GABORIT, PU PH
Seen in:
- Marseille, CHU Marseille
Trials:
- NCT03648554 (Principal Investigator)
Conditions:
- Diabetes Mellitus, Type 2;
- NASH - Nonalcoholic Steatohepatitis
Bertrand Cariou, MD
Seen in:
- Nantes, CHU de Nantes
- Nantes, Nantes UH
Trials:
- NCT04270656 (Principal Investigator)
- NCT04435054 (Principal Investigator)
Conditions:
- Type 2 Diabetes (T2D);
- Non-Alcoholic Fatty Liver Disease
Brigitte DELEMER
Seen in:
- Reims, CHU de Reims
Trials:
- NCT03648554 (Principal Investigator)
Conditions:
- Diabetes Mellitus, Type 2;
- NASH - Nonalcoholic Steatohepatitis
Bruno GUERCI
Seen in:
- Nancy, Service d'Endocrinologie, Diabétologie et Nutrition
- Vandœuvre-lès-Nancy, CHRU de Nancy
Trials:
- NCT03311516 (Principal Investigator)
- NCT03648554 (Principal Investigator)
Conditions:
Bruno MOULIN
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT04282447 (Sub-Investigator)
Conditions:
- Nonalcoholic Fatty Liver Disease
Bruno Verges, MD, PhD
Seen in:
- Dijon, Centre Hospitalier Universitaire Dijon Bourgogne
Trials:
- NCT04435054 (Principal Investigator)
Conditions:
- Non-Alcoholic Fatty Liver Disease
Camille BESCH
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
- Strasbourg, Service d'Imagerie Interventionnelle Vasculaire - CHU de Strasbourg - France
Trials:
- NCT05204251 (Sub-Investigator)
- NCT04282447 (Sub-Investigator)
Conditions:
- Chronic Liver Disease;
- Nonalcoholic Fatty Liver Disease
Christophe Aubé
Seen in:
- Angers, Angers University Hospital
Trials:
- NCT06080386 (Principal Investigator)
Conditions:
- Non Alcoholic Fatty Liver Disease
Christophe Bureau
Seen in:
- Cedex, Toulouse, CHU Rangueil
- Toulouse, Hopital Rangueil
Trials:
- NCT05639543 (Principal Investigator)
- NCT04166773 (Principal Investigator)
Conditions:
- Alcohol Associated Hepatitis;
- Nonalcoholic Steatohepatitis
Claire BRIET
Seen in:
- Angers, CHU
- Angers, CHU d'Angers
Trials:
- NCT04270656 (Principal Investigator)
- NCT06185491 (Principal Investigator)
Conditions:
- Type 2 Diabetes (T2D);
- Diabetes Mellitus
Cyrielle Caussy
Seen in:
- Lyon, Hospices Civils
- Pierre Benite Cedex, Centre Hospitalier Lyon Sud
- Pierre-Bénite, GSK Investigational Site
- Pierre-Bénite, Hopital Lyon Sud
Trials:
- NCT04166773 (Principal Investigator)
- NCT05583344 (Principal Investigator)
- NCT04270656 (Principal Investigator)
- NCT04435054 (Principal Investigator)
Conditions:
David REY
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT04282447 (Sub-Investigator)
Conditions:
- Nonalcoholic Fatty Liver Disease
David SAPIR, MD
Seen in:
- Melun, CH Melun
- Melun, Groupe Hospitalier Sud Ile de France (GHSIF) - Emergency Department
Trials:
- NCT03989999 (Principal Investigator)
- NCT05280145 (Principal Investigator)
Conditions:
Didier GOUET, MD
Seen in:
- La Rochette, CHU
Trials:
- NCT04270656 (Principal Investigator)
Conditions:
- Type 2 Diabetes (T2D)
Emmanuel CHATELUS
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT04282447 (Sub-Investigator)
Conditions:
- Nonalcoholic Fatty Liver Disease
Eric Vibert, MD, PhD
Seen in:
- Villejuif, Paul Brousse Hospital - APHP - Hepatobiliary Center
Trials:
- NCT05280145 (Principal Investigator)
Conditions:
Frederic PATAT, MD, PhD
Seen in:
- Tours, University Hospital of Tours
Trials:
- NCT02575625 (Principal Investigator)
Conditions:
- Liver Steatosis
Gaëtan PREVOST
Seen in:
- Rouen, CHU de Rouen
Trials:
- NCT03648554 (Principal Investigator)
Conditions:
- Diabetes Mellitus, Type 2;
- NASH - Nonalcoholic Steatohepatitis
Gérald ROUL
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT04282447 (Sub-Investigator)
Conditions:
- Nonalcoholic Fatty Liver Disease
Guillaume Lassailly, MD
Seen in:
- Lille, Hop Claude Huriez Chu Lille
- Lille, Hôpital Claude Huriez, CHRU
Trials:
- NCT04792801 (Principal Investigator)
- NCT03472157 (Principal Investigator)
Conditions:
Hélène Hanaire
Seen in:
- Toulouse Cedex, Chu Toulouse Hotel-Dieu Saint Jacques
- Toulouse, CHU Toulouse
- Toulouse, CHU de Toulouse
- Toulouse, Service de diabétologie, maladies métaboliques et nutrition
Trials:
- NCT03311516 (Principal Investigator)
- NCT03648554 (Principal Investigator)
- NCT05893797 (Principal Investigator)
- NCT05923827 (Principal Investigator)
Conditions:
Isabelle GUILHEM, MD
Seen in:
- Rennes, CHU de Rennes
Trials:
- NCT04270656 (Principal Investigator)
Conditions:
- Type 2 Diabetes (T2D)
Jacques-Eric GOTTENBERG
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT04282447 (Sub-Investigator)
Conditions:
- Nonalcoholic Fatty Liver Disease
Jean-Charles NAULT, MD, PhD
Seen in:
- Bobigny, Avicenne Hospital - APHP- Hepatology Department
Trials:
- NCT05280145 (Principal Investigator)
Conditions:

Clinical Trials on Fatty Liver

Shiraz University of Medical Sciences

Completed

The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease (ThymeLiv)

Fatty Liver | Fatty Liver, Nonalcoholic

Iran, Islamic Republic of
Hoffmann-La Roche

Completed

A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease

Fatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD

Germany, Austria
Genfit

Terminated

Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)

Non-Alcoholic Fatty Liver

Netherlands
Medical College of Wisconsin
ENDRA Life Sciences, Inc.

Recruiting

Assessment of Fatty Liver With Thermo-acoustic Device

Fatty Liver | NAFLD | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty Liver | NASH | Fatty Liver Disease

United States
Cairo University

Recruiting

Calisthenics Versus High Intensity Interval Training in NAFL

Non-Alcoholic Fatty Liver Disease

Egypt
Miriam Vos, MD
Immuron Ltd.; Advanced MR Analytics AB

Completed

Anti-LPS Antibody Treatment for Pediatric NAFLD

Nonalcoholic Fatty Liver Disease (NAFLD)

United States
Nehal Abou Seada

Completed

Efficacy of Phosphatidylcholine in NAFLD

Non-Alcoholic Fatty Liver Disease
HaEmek Medical Center, Israel

Terminated

Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease (FLM)

Patients With Fatty Liver Disease

Israel
AB Biotics, SA

Completed

Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

Non Alcoholic Fatty Liver

Mexico
University of L'Aquila

Recruiting

Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease) (NAFLD)

NAFLD- Non Alcoholic Fatty Liver Disease

Italy

Medical specialists from France tagged as investigators in clinical trials studying Fatty Liver

Clinical Trials on Fatty Liver

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations